Bartlett & Co’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $15.2M | Buy |
26,169
+505
| +2% | +$295K | 0.25% | 75 |
|
|
2023
Q3 | $13.8M | Buy |
25,664
+66
| +0.3% | +$34K | 0.25% | 82 |
|
|
2023
Q2 | $12M | Buy |
25,598
+3,255
| +15% | +$1.37M | 0.21% | 86 |
|
|
2023
Q1 | $7.67M | Buy |
22,343
+534
| +2% | +$180K | 0.15% | 108 |
|
|
2022
Q4 | $7.98M | Sell |
21,809
-155
| -0.7% | -$55K | 0.16% | 108 |
|
|
2022
Q3 | $7.1M | Sell |
21,964
-196
| -0.9% | -$62.1K | 0.15% | 107 |
|
|
2022
Q2 | $7.18M | Sell |
22,160
-168
| -0.8% | -$50.4K | 0.15% | 109 |
|
|
2022
Q1 | $6.39M | Buy |
22,328
+126
| +0.6% | +$32.4K | 0.11% | 119 |
|
|
2021
Q4 | $6.13M | Buy |
22,202
+1,411
| +7% | +$358K | 0.1% | 123 |
|
|
2021
Q3 | $4.8M | Buy |
20,791
+505
| +2% | +$125K | 0.09% | 127 |
|
|
2021
Q2 | $4.66M | Sell |
20,286
-100
| -0.5% | -$20.1K | 0.09% | 130 |
|
|
2021
Q1 | $3.81M | Sell |
20,386
-290
| -1% | -$56.7K | 0.08% | 135 |
|
|
2020
Q4 | $3.49M | Sell |
20,676
-31
| -0.1% | -$4.63K | 0.07% | 142 |
|
|
2020
Q3 | $3.06M | Buy |
20,707
+15
| +0.1% | +$2.32K | 0.07% | 140 |
|
|
2020
Q2 | $3.4M | Buy |
20,692
+1,175
| +6% | +$180K | 0.09% | 134 |
|
|
2020
Q1 | $2.71M | Buy |
+19,517
| New | +$2.68M | 0.08% | 138 |
|
|
2019
Q3 | $2.24M | Buy |
20,013
+11,010
| +122% | +$1.23M | 0.06% | 162 |
|
|
2019
Q2 | $997K | Buy |
9,003
+11
| +0.1% | +$1.29K | 0.04% | 170 |
|
|
2019
Q1 | $1.17M | Buy |
8,992
+50
| +0.6% | +$6.08K | 0.04% | 159 |
|
|
2018
Q4 | $1.03M | Sell |
8,942
-265
| -3% | -$29.6K | 0.04% | 161 |
|
|
2018
Q3 | $988K | Sell |
9,207
-160
| -2% | -$16K | 0.04% | 166 |
|
|
2018
Q2 | $799K | Hold |
9,367
| – | – | 0.03% | 176 |
|
|
2018
Q1 | $725K | Sell |
9,367
-304
| -3% | -$24.5K | 0.03% | 179 |
|
|
2017
Q4 | $817K | Hold |
9,671
| – | – | 0.03% | 177 |
|
|
2017
Q3 | $827K | Sell |
9,671
-101
| -1% | -$8.28K | 0.03% | 164 |
|
|
2017
Q2 | $804K | Hold |
9,772
| – | – | 0.04% | 168 |
|
|
2017
Q1 | $822K | Hold |
9,772
| – | – | 0.04% | 165 |
|
|
2016
Q4 | $719K | Hold |
9,772
| – | – | 0.03% | 166 |
|
|
2016
Q3 | $784K | Buy |
9,772
+101
| +1% | +$8.08K | 0.04% | 159 |
|
|
2016
Q2 | $762K | Buy |
9,671
+2,083
| +27% | +$157K | 0.04% | 158 |
|
|
2016
Q1 | $546K | Buy |
7,588
+450
| +6% | +$34K | 0.03% | 181 |
|
|
2015
Q4 | $601K | Hold |
7,138
| – | – | 0.03% | 178 |
|
|
2015
Q3 | $597K | Sell |
7,138
-160
| -2% | -$13.5K | 0.03% | 168 |
|
|
2015
Q2 | $609K | Sell |
7,298
-165
| -2% | -$12.6K | 0.03% | 172 |
|
|
2015
Q1 | $542K | Sell |
7,463
-200
| -3% | -$14.2K | 0.03% | 180 |
|
|
2014
Q4 | $529K | Buy |
7,663
+817
| +12% | +$55.1K | 0.03% | 179 |
|
|
2014
Q3 | $444K | Hold |
6,846
| – | – | 0.02% | 198 |
|
|
2014
Q2 | $426K | Sell |
6,846
-1,147
| -14% | -$68.4K | 0.02% | 202 |
|
|
2014
Q1 | $470K | Sell |
7,993
-100
| -1% | -$5.58K | 0.02% | 192 |
|
|
2013
Q4 | $413K | Hold |
8,093
| – | – | 0.02% | 197 |
|
|
2013
Q3 | $407K | Hold |
8,093
| – | – | 0.02% | 193 |
|
|
2013
Q2 | $398K | Buy |
+8,093
| New | +$440K | 0.02% | 191 |
|
Other funds holding LLY
Bartlett & Co's LLY Position: Q4 2023 in Review
Bartlett & Co increased its Eli Lilly (LLY) stake by 2% in Q4 2023, buying an estimated $295K and bringing the position to 26,169 shares worth $15.2M. The position accounts for 0.25% of the portfolio, ranked #75.
Bartlett & Co first reported a position in LLY in Q2 2013 and has held it in 42 quarters since. 3,272 funds tracked by Wall St. Rank hold LLY as of Q4 2023.
- Bartlett & Co held 26,169 shares of Eli Lilly worth $15.2M as of Q4 2023.
- Bartlett & Co bought 505 Eli Lilly shares in Q4 2023, an estimated $295K.
- Eli Lilly made up 0.25% of Bartlett & Co's portfolio in Q4 2023, its #75 holding.
- Bartlett & Co first reported a position in Eli Lilly in Q2 2013 and has held it in 42 quarters since.
- 3,272 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2023.
Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.